from Reuters: Health https://reut.rs/2FRFWe6
Monday, April 8, 2019
Health Canada plans to suspend Allergan's breast implant license
Health Canada plans to suspend the license for Allergan Plc's Biocell breast implant due to the risk of a rare cancer linked to such implants, the regulator said in a notice to the Botox-maker on Thursday.
from Reuters: Health https://reut.rs/2FRFWe6
from Reuters: Health https://reut.rs/2FRFWe6
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment